Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bharti Mangla

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
International Journal of Biometeorology|September 29, 2025
Advancing nanomedicine for military cold-zone operations: a global perspective on innovations in nanomedicine and future directionsPankaj Kumar, Bharti Mangla
Phytotherapy Research : PTR|March 8, 2022
From propolis to nanopropolis: An exemplary journey and a paradigm shift of a resinous substance produced by beesShamama Javed, Bharti Mangla, Waquar Ahsan
Medical Oncology (Northwood, London, England)|June 12, 2024
Multifaceted role of erlotinib in various cancer: nanotechnology intervention, patent landscape, and advancements in clinical trialsBharti Mangla, Priya Mittal, Pankaj Kumar, et al.
Journal of Liposome Research|December 4, 2025
Formulation optimization and biodistribution of epigallocatechin gallate phospholipid complex-loaded NLCs for rheumatoid arthritis treatmentBharti Mangla, Shanu Yadav, Pankaj Kumar, et al.
Nanomedicine (London, England)|May 26, 2025
Development and <i>in vivo</i> biodistribution of folate-targeted nanolipid system for erlotinib in breast cancer treatmentBharti Mangla, Tabish Pathan, Pankaj Kumar, et al.
Journal of Pharmaceutical Sciences|June 16, 2019
Nanostructured Lipid Carriers for Oral Bioavailability Enhancement of Exemestane: Formulation Design, In Vitro, Ex Vivo, and In Vivo StudiesArchu Singh, Yub Raj Neupane, Bharti Mangla, et al.
Medical Hypotheses|August 28, 2019
Tamoxifen and Sulphoraphane for the breast cancer management: A synergistic nanomedicine approachBharti Mangla, Yub Raj Neupane, Archu Singh, et al.
International Journal of Pharmaceutics|August 17, 2024
Oral in vivo biodistribution of fluorescent labelled nano lipid carrier system of erlotinib using real time optical imaging techniquePankaj Kumar, Bharti Mangla, Sayed Akthar Imam, et al.
Critical Reviews in Therapeutic Drug Carrier Systems|September 1, 2020
Reassessment of Therapeutic Applications of Carbon Nanotubes: A Majestic and Futuristic Drug CarrierBharti Mangla, Shamama Javed, Kanchan Kohli, et al.
Anti-Cancer Agents in Medicinal Chemistry|October 9, 2023
Multivariate Statistical 2D QSAR Analysis of Indenoisoquinoline-based Topoisomerase- I Inhibitors as Anti-lung Cancer AgentsSupriya Singh, Bharti Mangla, Shamama Javed, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
International Journal of Biometeorology|September 29, 2025
Advancing nanomedicine for military cold-zone operations: a global perspective on innovations in nanomedicine and future directionsPankaj Kumar, Bharti Mangla
Phytotherapy Research : PTR|March 8, 2022
From propolis to nanopropolis: An exemplary journey and a paradigm shift of a resinous substance produced by beesShamama Javed, Bharti Mangla, Waquar Ahsan
Medical Oncology (Northwood, London, England)|June 12, 2024
Multifaceted role of erlotinib in various cancer: nanotechnology intervention, patent landscape, and advancements in clinical trialsBharti Mangla, Priya Mittal, Pankaj Kumar, et al.
Journal of Liposome Research|December 4, 2025
Formulation optimization and biodistribution of epigallocatechin gallate phospholipid complex-loaded NLCs for rheumatoid arthritis treatmentBharti Mangla, Shanu Yadav, Pankaj Kumar, et al.
Nanomedicine (London, England)|May 26, 2025
Development and <i>in vivo</i> biodistribution of folate-targeted nanolipid system for erlotinib in breast cancer treatmentBharti Mangla, Tabish Pathan, Pankaj Kumar, et al.
Journal of Pharmaceutical Sciences|June 16, 2019
Nanostructured Lipid Carriers for Oral Bioavailability Enhancement of Exemestane: Formulation Design, In Vitro, Ex Vivo, and In Vivo StudiesArchu Singh, Yub Raj Neupane, Bharti Mangla, et al.
Medical Hypotheses|August 28, 2019
Tamoxifen and Sulphoraphane for the breast cancer management: A synergistic nanomedicine approachBharti Mangla, Yub Raj Neupane, Archu Singh, et al.
International Journal of Pharmaceutics|August 17, 2024
Oral in vivo biodistribution of fluorescent labelled nano lipid carrier system of erlotinib using real time optical imaging techniquePankaj Kumar, Bharti Mangla, Sayed Akthar Imam, et al.
Critical Reviews in Therapeutic Drug Carrier Systems|September 1, 2020
Reassessment of Therapeutic Applications of Carbon Nanotubes: A Majestic and Futuristic Drug CarrierBharti Mangla, Shamama Javed, Kanchan Kohli, et al.
Anti-Cancer Agents in Medicinal Chemistry|October 9, 2023
Multivariate Statistical 2D QSAR Analysis of Indenoisoquinoline-based Topoisomerase- I Inhibitors as Anti-lung Cancer AgentsSupriya Singh, Bharti Mangla, Shamama Javed, et al.
Pageof 4